x
- Home
- About Diabetes
- Services
- Diabetes Mellitus Modeling Solutions
- R&D Services for Diabetes Mellitus and Diabetic Complications
- By Drug Development Process
- About Us
- Careers
- Contact Us
Cat. No.: DIA-0230123
| Product Information | |
|---|---|
| CAS No. | 372164-71-1 |
| Chemical Name | (3Z)-3-(1H-Imidazol-5-ylmethylidene)-1H-indol-2-one |
| Formula | C12H9N3O |
| Molecular Weight | 211.22 |
| PubChem CID | 5714572 |
| SMILES | C1=CC=C2C(=C1)/C(=C/C3=CN=CN3)/C(=O)N2 |
| Target | Cdks |
| Product Description | ATP-competitive Aurora A and B inhibitor |
| Format & Storage | |
|---|---|
| Purity | > 98% |
| Source | Synthetic |
| Shipping | Shipped on dry ice. |
| Storage | Store at -20 °C. It is important to note that this product is reported to be light sensitive. Store In the Dark. Store under desiccating conditions. |
| Solubility Overview | Soluble in DMSO to 10 mM |
Ace Therapeutics has a team of experts in the field of endocrine and metabolic research, aiming to provide innovative preclinical contract research solutions to cope with diabetes and its complications. We provide customized solutions and technical support, enabling the transformation of promising concepts into innovative treatments, thus accelerating the drug development process of diabetes.
